Position in NGNE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,069,300
+$202,420 QoQ
Shares Held
34,000
-20.9% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 112 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NGNE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Raiffeisen Bank International AG holds $103,697,949 across 27 Biotechnology names. NGNE ranks #19 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
97,170 | $48,267,254 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,423 | $15,852,257 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,510 | $4,066,915 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
20,101 | $3,764,515 | |
| 5 | BNTX |
BioNTech SE
|
35,000 | $3,256,750 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
35,000 | $2,775,150 | |
| 7 | LEGN |
Legend Biotech Corp
|
80,000 | $2,310,400 | |
| 8 | ALLO |
Allogene Therapeutics, Inc.
|
1,100,000 | $2,288,000 |
All Filings in NGNE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,069,300 | 34,000 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $866,880 | 43,000 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $865,200 | 42,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $589,220 | 34,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $448,500 | 30,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $351,300 | 30,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $365,760 | 16,000 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||